Cumberland Pharmaceuticals Inc (CPIX): Total Assets
$76.82M
As of 2025-12-31
$62.88M
As of 2026-06-30
-6.1%
3-year compound annual growth
-4.5%
5-year compound annual growth
-1.8%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $76.82M | +1.6% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $75.58M | -7.6% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $81.78M | -12.0% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $92.93M | +10.0% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $84.46M | -12.4% | 2023-03-13, Balance as of period end |
| 2020-12-31 | $96.46M | -7.7% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $104.55M | -7.2% | 2021-03-12, Balance as of period end |
| 2018-12-31 | $112.69M | +20.9% | 2020-03-20, Balance as of period end |
| 2017-12-31 | $93.23M | -0.2% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $93.40M | +1.6% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $91.92M | -3.7% | 2017-03-13, Balance as of period end |
| 2014-12-31 | $95.41M | +8.9% | 2016-03-14, Balance as of period end |
| 2013-12-31 | $87.61M | -11.1% | 2015-03-09, Balance as of period end |
| 2012-12-31 | $98.59M | +3.2% | 2014-03-11, Balance as of period end |
| 2011-12-31 | $95.52M | +3.8% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $92.05M | n/a | 2012-03-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $76.82M | +1.6% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $160.43M | +58.2% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $154.69M | +117.6% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $596.19M | +30.6% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $668.19M | -10.3% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $638.50M | +81.3% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $28.56M | +29.2% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $172.25M | -45.4% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $184.99M | -38.0% |
Compare CPIX, AQST, XLO, SEPN side by side · Screen every company in Pharmaceutical Preparations ↗